A detailed history of Van Hulzen Asset Management, LLC transactions in Danaher Corp stock. As of the latest transaction made, Van Hulzen Asset Management, LLC holds 75,584 shares of DHR stock, worth $17.3 Million. This represents 1.52% of its overall portfolio holdings.

Number of Shares
75,584
Previous 93,784 19.41%
Holding current value
$17.3 Million
Previous $23.4 Million 10.32%
% of portfolio
1.52%
Previous 1.57%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$239.25 - $280.76 $4.35 Million - $5.11 Million
-18,200 Reduced 19.41%
75,584 $21 Million
Q2 2024

Aug 07, 2024

BUY
$235.51 - $267.98 $1.82 Million - $2.08 Million
7,746 Added 9.0%
93,784 $23.4 Million
Q1 2024

May 06, 2024

BUY
$224.58 - $256.19 $676,434 - $771,644
3,012 Added 3.63%
86,038 $21.5 Million
Q4 2023

Feb 07, 2024

BUY
$185.1 - $233.13 $358,908 - $452,039
1,939 Added 2.39%
83,026 $19.2 Million
Q3 2023

Nov 07, 2023

BUY
$233.08 - $265.59 $3.89 Million - $4.43 Million
16,673 Added 25.88%
81,087 $20.1 Million
Q2 2023

Aug 03, 2023

BUY
$224.99 - $256.14 $10 Million - $11.4 Million
44,525 Added 223.87%
64,414 $15.5 Million
Q1 2023

Apr 28, 2023

BUY
$239.75 - $277.0 $851,831 - $984,181
3,553 Added 21.75%
19,889 $5.01 Million
Q4 2022

Feb 13, 2023

BUY
$241.42 - $282.29 $34,523 - $40,367
143 Added 0.88%
16,336 $4.33 Million
Q3 2022

Nov 08, 2022

BUY
$247.06 - $1507.4 $1.5 Million - $9.14 Million
6,064 Added 59.87%
16,193 $4.18 Million
Q2 2022

Aug 04, 2022

BUY
$237.11 - $299.66 $126,853 - $160,318
535 Added 5.58%
10,129 $2.57 Million
Q1 2022

May 20, 2022

BUY
$257.27 - $315.76 $172,885 - $212,190
672 Added 7.53%
9,594 $2.81 Million
Q4 2021

Feb 04, 2022

BUY
$292.08 - $329.01 $55,203 - $62,182
189 Added 2.16%
8,922 $2.94 Million
Q3 2021

Nov 12, 2021

BUY
$272.21 - $332.43 $14,971 - $18,283
55 Added 0.63%
8,733 $2.66 Million
Q2 2021

Aug 06, 2021

BUY
$225.08 - $271.69 $97,009 - $117,098
431 Added 5.23%
8,678 $2.33 Million
Q1 2021

May 12, 2021

SELL
$212.38 - $245.9 $175,213 - $202,867
-825 Reduced 9.09%
8,247 $1.86 Million
Q4 2020

Feb 16, 2021

SELL
$212.5 - $245.46 $223,762 - $258,469
-1,053 Reduced 10.4%
9,072 $2.02 Million
Q3 2020

Nov 03, 2020

SELL
$177.16 - $215.33 $137,830 - $167,526
-778 Reduced 7.14%
10,125 $2.18 Million
Q2 2020

Aug 11, 2020

SELL
$128.7 - $176.83 $154,311 - $212,019
-1,199 Reduced 9.91%
10,903 $1.93 Million
Q1 2020

May 14, 2020

BUY
$121.39 - $169.05 $1.22 Million - $1.71 Million
10,088 Added 500.89%
12,102 $1.68 Million
Q4 2019

Feb 12, 2020

SELL
$133.47 - $153.48 $1.35 Million - $1.55 Million
-10,094 Reduced 83.37%
2,014 $309,000
Q3 2019

Oct 30, 2019

SELL
$135.4 - $146.47 $35,068 - $37,935
-259 Reduced 2.09%
12,108 $1.75 Million
Q2 2019

Aug 08, 2019

BUY
$124.88 - $143.73 $33,093 - $38,088
265 Added 2.19%
12,367 $1.77 Million
Q1 2019

May 01, 2019

SELL
$97.62 - $132.29 $894,882 - $1.21 Million
-9,167 Reduced 43.1%
12,102 $1.6 Million
Q4 2018

Feb 12, 2019

SELL
$94.85 - $109.54 $107,654 - $124,327
-1,135 Reduced 5.07%
21,269 $2.19 Million
Q3 2018

Nov 14, 2018

BUY
$98.13 - $108.9 $64,275 - $71,329
655 Added 3.01%
22,404 $2.43 Million
Q2 2018

Aug 07, 2018

BUY
$96.1 - $103.24 $686,442 - $737,443
7,143 Added 48.9%
21,749 $2.15 Million
Q1 2018

May 08, 2018

SELL
$92.16 - $103.8 $553,512 - $623,422
-6,006 Reduced 29.14%
14,606 $1.43 Million
Q4 2017

Feb 12, 2018

SELL
$85.26 - $94.62 $3 Million - $3.32 Million
-35,135 Reduced 63.03%
20,612 $1.91 Million
Q3 2017

Nov 09, 2017

BUY
$79.29 - $88.45 $3.37 Million - $3.76 Million
42,543 Added 322.2%
55,747 $4.78 Million
Q2 2017

Aug 14, 2017

BUY
N/A
13,204
13,204 $1.11 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $166B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Van Hulzen Asset Management, LLC Portfolio

Follow Van Hulzen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Hulzen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Van Hulzen Asset Management, LLC with notifications on news.